Latest Takeda Pharmaceuticals Stories
Exemplary companies and organizations to be honored March 3 during 2015 ASAP Global Alliance Summit for outstanding partnering, alliance programs, and collaboration efforts ranging from combatting
Case Funding Firm adds to funding amounts as Bellwether trials kick into high gear after $9Bil verdict is failed to be dismissed on Takeda post-trial motion. HOUSTON, Sept.
Actos Lawsuit Help Center Website reports that Takeda and Eli Lilly loses bid to have Judge throw out recent $9Bil Jury verdict. NEW ORLEANS, Sept.
Primary Research Provides Key Insights and Tools for Health Care Professionals DEERFIELD, Ill. and ALEXANDRIA, Va., Sept.
A jury in Louisiana has determined that Takeda Pharmaceuticals and Eli Lilly & Co.
Flood Law Group continues to investigate potential Actos lawsuits on behalf of patients who developed bladder cancer after taking Actos in light of the recent developments in Actos litigation.
The Firm is evaluating Actos lawsuits on behalf of patients who developed bladder cancer, allegedly due to long-term use of the Type 2 diabetes drug. New York,
The Firm is investigating Actos lawsuits on behalf of individuals who allegedly developed bladder cancer after using Actos for a year or more. New York, NY (PRWEB)
Huge amount of damages awarded to New York man who was diagnosed with bladder cancer that jurors were told was caused by diabetes drug Actos.
The Japanese drug maker that was recently ordered to pay $6 billion to a man who claimed that his bladder cancer diagnosis was caused by Actos, makes several other drugs with the same active ingredient.